Roger Slater

462 total citations
14 papers, 337 citations indexed

About

Roger Slater is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Roger Slater has authored 14 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Toxicology. Recurrent topics in Roger Slater's work include Bioactive Compounds and Antitumor Agents (2 papers), Synthesis and Reactions of Organic Compounds (2 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (2 papers). Roger Slater is often cited by papers focused on Bioactive Compounds and Antitumor Agents (2 papers), Synthesis and Reactions of Organic Compounds (2 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (2 papers). Roger Slater collaborates with scholars based in United Kingdom, United States and Netherlands. Roger Slater's co-authors include Alan E. Wakeling, John Kemp, Hugh K. Adam, Graham J. Durant, J. C. EMMETT, C. Robin Ganellin, William Howson, William V. Glenn, Mìchael L. Rhodes and Willem Den Otter and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Cancer and IEEE Transactions on Biomedical Engineering.

In The Last Decade

Roger Slater

13 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Slater United Kingdom 9 96 56 55 37 29 14 337
Xiang‐Rong Jiang United States 8 115 1.2× 52 0.9× 149 2.7× 28 0.8× 23 0.8× 13 358
Jamie Munro United Kingdom 3 160 1.7× 17 0.3× 31 0.6× 29 0.8× 16 0.6× 4 411
Yuzhe Xing Canada 7 195 2.0× 165 2.9× 44 0.8× 65 1.8× 34 1.2× 7 496
Matti Lepistö Sweden 11 201 2.1× 99 1.8× 74 1.3× 29 0.8× 20 0.7× 16 378
Debra K. Breuer United States 5 213 2.2× 29 0.5× 78 1.4× 17 0.5× 103 3.6× 5 394
Mária Ďurišová Slovakia 15 147 1.5× 24 0.4× 19 0.3× 37 1.0× 52 1.8× 82 674
Deepa Rungta United States 11 265 2.8× 65 1.2× 134 2.4× 33 0.9× 32 1.1× 17 392
Jens‐Kerim Ergüden Germany 6 147 1.5× 107 1.9× 29 0.5× 21 0.6× 25 0.9× 8 423
Claus Bretting Denmark 5 124 1.3× 73 1.3× 139 2.5× 30 0.8× 8 0.3× 6 391
Cathy Tralau-Stewart United Kingdom 7 183 1.9× 37 0.7× 39 0.7× 55 1.5× 34 1.2× 11 411

Countries citing papers authored by Roger Slater

Since Specialization
Citations

This map shows the geographic impact of Roger Slater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Slater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Slater more than expected).

Fields of papers citing papers by Roger Slater

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Slater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Slater. The network helps show where Roger Slater may publish in the future.

Co-authorship network of co-authors of Roger Slater

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Slater. A scholar is included among the top collaborators of Roger Slater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Slater. Roger Slater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Siddiqui, Faisal, et al.. (2009). Life threatening hyperkalemia following cocaine ingestion: a case report. Cases Journal. 2(1). 7355–7355. 2 indexed citations
2.
Slater, Roger, et al.. (1993). Growth of cultured human glioma tumour cells can be regulated with histamine and histamine antagonists. British Journal of Cancer. 68(3). 475–483. 20 indexed citations
3.
Slater, Roger, et al.. (1989). Quantitative techniques in a business context. Medical Entomology and Zoology. 1 indexed citations
4.
5.
Slater, Roger, et al.. (1988). Design and synthesis of a series of combined vasodilator-.beta.-adrenoceptor antagonists based on 6-arylpyridazinones. Journal of Medicinal Chemistry. 31(2). 345–351. 26 indexed citations
6.
Owen, D. A. A., et al.. (1987). SK & F 95018, a vasodilator/beta-adrenoceptor antagonist.. PubMed. 289(2). 251–66. 2 indexed citations
7.
Truong, T. K., et al.. (1985). A New CT-Aided Stereotactic Neurosurgery Technique. IEEE Transactions on Biomedical Engineering. BME-32(7). 540–544. 2 indexed citations
8.
Slater, Roger, et al.. (1985). Quantitative Methods for Business Decisions. Medical Entomology and Zoology. 86 indexed citations
9.
10.
Kemp, John, Hugh K. Adam, Alan E. Wakeling, & Roger Slater. (1983). Identification and biological activity of tamoxifen metabolites in human serum. Biochemical Pharmacology. 32(13). 2045–2052. 72 indexed citations
11.
Rhodes, Mìchael L., et al.. (1982). Stereotactic neurosurgery using 3-D image data from computed tomography. Journal of Medical Systems. 6(1). 105–119. 18 indexed citations
12.
Slater, Roger, et al.. (1979). SK&F 92657, a Novel Antihypertensive Acting by Precapillary Vasodilatation and β-Adrenoreceptor Blockade. Clinical Science. 57(s5). 433s–436s. 29 indexed citations
13.
Durant, Graham J., et al.. (1976). Potential histamine H2-receptor antagonists. 3. Methylhistamines. Journal of Medicinal Chemistry. 19(7). 923–928. 56 indexed citations
14.
Slater, Roger, et al.. (1965). INFRACLAVICULAR SUBCLAVIAN ANGIOGRAPHY BY PERCUTANEOUS PUNCTURE.. PubMed. 103. 16–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiang‐Rong Jiang Breakdown of academic impact, for papers by Jamie Munro Breakdown of academic impact, for papers by Yuzhe Xing Breakdown of academic impact, for papers by Matti Lepistö Breakdown of academic impact, for papers by Debra K. Breuer Breakdown of academic impact, for papers by Mária Ďurišová Breakdown of academic impact, for papers by Deepa Rungta Breakdown of academic impact, for papers by Jens‐Kerim Ergüden Breakdown of academic impact, for papers by Claus Bretting Breakdown of academic impact, for papers by Cathy Tralau-Stewart
Rankless by CCL
2026